10月5日，Twist Bioscience盘中上涨5.55%，报199.14美元。
消息面上，此前公司公告拟议出售证券，引发市场交易异动。事件背景显示，Twist Bioscience Corp已正式提交144表格报告证券出售计划，该文件通常涉及内部人或大股东减持，可能导致投资者情绪波动。
Twist Bioscience Corporation致力于为那些正在把世界变得更好的客户服务，在卫生保健、食品/农业等领域利用合成DNA工具开发改善方案。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.